DelveInsight’s Amyotrophic Lateral Sclerosis market report thoroughly explains the Amyotrophic Lateral Sclerosis, historical and forecasted epidemiology, as well as the Amyotrophic Lateral Sclerosis market trends in the 7MM.
Some of the Key Highlights from the Amyotrophic Lateral Sclerosis Market Report
Have queries? Request for the sample @ Amyotrophic Lateral Sclerosis Market Outlook
Amyotrophic Lateral Sclerosis: Overview
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a rare neurological disease that primarily affects the nerve cells (neurons) that control voluntary muscle movement. Voluntary muscles are responsible for activities such as chewing, walking, and talking. The disease is progressive, which means that the symptoms worsen over time.
Amyotrophic Lateral Sclerosis Epidemiology Segmentation
The Amyotrophic Lateral Sclerosis report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
Amyotrophic Lateral Sclerosis Treatment Landscape
The major ALS treatment options include:
Amyotrophic Lateral Sclerosis Market Outlook
According to estimates, the largest ALS market size was found in the United States, while the smallest was found in Spain across the 7MM. Furthermore, the upcoming ALS therapies such as NurOwn, Arimoclomol, Ibudilast, and others are expected to address the current unmet needs of ALS patients while also contributing to the overall growth of the ALS market size.
Learn more about the emerging therapies and companies @ ALS Pipeline Therapies
Table of Contents
1.
Key Insights
2.
Executive Summary
3.
Amyotrophic Lateral Sclerosis (ALS) Market Overview at a Glance
4.
Disease Background and Overview: Amyotrophic Lateral Sclerosis (ALS)
5.
European Federation of Neurological Societies (EFNS) guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) (2012)
6.
Recognized Establishments
7.
Treatment and Management of ALS
8.
American Association of Neurology (AAN) Guidelines for Care and Management of patients with ALS (2009)
9.
Management Algorithm for Respiratory Dysfunction in ALS
10.
Management guidelines for ALS in Japan, the United States, and Europe
11.
Epidemiology and Patient Population
12.
Country Wise-Epidemiology of Amyotrophic Lateral Sclerosis
13.
Unmet Needs
14.
Marketed Drugs
15.
Emerging Drugs
16.
Market Access and Reimbursement
17.
Amyotrophic Lateral Sclerosis (ALS): Seven Major Market Analysis
18.
7MM Market Outlook
19.
Case Reports
20.
Market Drivers
21.
Market Barriers
22.
SWOT Analysis
23.
Appendix
24.
DelveInsight Capabilities
25.
Disclaimer
26.
About DelveInsight
Get in touch with our business executive for Healthcare Due Diligence Services
Related Reports
Amyloidosis Market
DelveInsight’s “Amyloidosis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Amyloidosis, historical and forecasted epidemiology, as well as the Amyloidosis market trends in the 7MM.
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Sandeep JoshiEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: www.delveinsight.com/